Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan O'Brien

Showing results (11-20 of 643) with videos related to

Pageof 65
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 20, 2026
Highlights in chronic lymphocytic leukemia from the 67th ASH Annual Meeting and Exposition: commentarySusan O'Brien
Journal of Oncology Practice|February 15, 2019
Poor Penetration of Existing Effective Chemoimmunotherapy for the Treatment of Older Patients With Newly Diagnosed Acute Lymphocytic Leukemia (ALL) or Refractory/Relapsed ALLHagop Kantarjian, Susan O'Brien
Blood|June 13, 2015
Initial treatment of CLL: integrating biology and functional statusNitin Jain, Susan O'Brien
Hematology. American Society of Hematology. Education Program|December 4, 2016
Novel agents in chronic lymphocytic leukemiaNicole Lamanna, Susan O'Brien
Best Practice & Research. Clinical Haematology|October 16, 2016
B cell receptor inhibition as a target for CLL therapyDeepa Jeyakumar, Susan O'Brien
Blood Reviews|June 21, 2005
Infections associated with purine analogs and monoclonal antibodiesFarhad Ravandi, Susan O'Brien
Expert Review of Anticancer Therapy|March 11, 2005
AlemtuzumabFarhad Ravandi, Susan O'Brien
Cancer Investigation|November 23, 2006
Alemtuzumab in CLL and other lymphoid neoplasmsFarhad Ravandi, Susan O'brien
Oncology (Williston Park, N.Y.)|January 22, 2013
Chronic lymphocytic leukemia with deletion 17p: emerging treatment optionsNitin Jain, Susan O'Brien
Expert Opinion on Biological Therapy|December 22, 2012
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemiaPreetesh Jain, Susan O'Brien
Pageof 65

Showing results (11-20 of 643) with videos related to

Sort By:
Pageof 65
Clinical Advances in Hematology & Oncology : H&O|February 20, 2026
Highlights in chronic lymphocytic leukemia from the 67th ASH Annual Meeting and Exposition: commentarySusan O'Brien
Journal of Oncology Practice|February 15, 2019
Poor Penetration of Existing Effective Chemoimmunotherapy for the Treatment of Older Patients With Newly Diagnosed Acute Lymphocytic Leukemia (ALL) or Refractory/Relapsed ALLHagop Kantarjian, Susan O'Brien
Blood|June 13, 2015
Initial treatment of CLL: integrating biology and functional statusNitin Jain, Susan O'Brien
Hematology. American Society of Hematology. Education Program|December 4, 2016
Novel agents in chronic lymphocytic leukemiaNicole Lamanna, Susan O'Brien
Best Practice & Research. Clinical Haematology|October 16, 2016
B cell receptor inhibition as a target for CLL therapyDeepa Jeyakumar, Susan O'Brien
Blood Reviews|June 21, 2005
Infections associated with purine analogs and monoclonal antibodiesFarhad Ravandi, Susan O'Brien
Expert Review of Anticancer Therapy|March 11, 2005
AlemtuzumabFarhad Ravandi, Susan O'Brien
Cancer Investigation|November 23, 2006
Alemtuzumab in CLL and other lymphoid neoplasmsFarhad Ravandi, Susan O'brien
Oncology (Williston Park, N.Y.)|January 22, 2013
Chronic lymphocytic leukemia with deletion 17p: emerging treatment optionsNitin Jain, Susan O'Brien
Expert Opinion on Biological Therapy|December 22, 2012
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemiaPreetesh Jain, Susan O'Brien
Pageof 65